JHOP - March 2013 VOL 3, NO 1

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

View Digital Edition

Original Article

Pharmacist Assessment of Polypharmacy Risks in Patients with Cancer

Robert Mancini, PharmD, BCOP, FHOPA, Kathleen Clifford, MSN, FNP-BC, AOCNP, ACHPN

Drug Profiles/Updates

Ipilimumab: Unique Responses, Toxicities, and Recommendations for the Use of the First Anti–CTLA-4 Therapy in Patients with Melanoma

Michael K.K. Wong, MD, PhD, FRCPC, Anthony Jarkowski III, PharmD, BCOP

Letters to the Editor

Impact of Pharmacists’ Intervention in Altering Prescribing Patterns for the Treatment of VTE in Patients with Cancer

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Results 1 - 4 of 4